Regulation of the Synaptic Vesicle Cycle and Mitochondrial Morphology by Alpha-Synuclein
Skip to main content
Open Access Publications from the University of California


UC San Francisco Electronic Theses and Dissertations bannerUCSF

Regulation of the Synaptic Vesicle Cycle and Mitochondrial Morphology by Alpha-Synuclein

  • Author(s): Nemani, Venu Maadhav
  • Advisor(s): Edwards, Robert
  • et al.

Neurodegenerative diseases are characterized by the accumulation and aggregation of particular proteins. In most cases, very little is known about the physiological function of these proteins; further, the manner in which their normal functions may contribute to the initiation of disease has not been well studied.

The protein alpha-synuclein has been implicated in both sporadic and familial forms of Parkinson's disease. Three point mutations in alpha-synuclein cause dominantly inherited forms of the disease, implying a causative role in the disorder. Although it localizes to nerve terminals, its role in neurotransmitter release remains poorly understood. Recently, it has been shown that modest increases in alpha-synuclein protein expression are sufficient to cause Parkinson's disease, suggesting that an increase in its normal function may initiate degeneration.

To understand the role of increased alpha-synuclein expression on nerve terminal physiology, we overexpressed alpha-synuclein in hippocampal neurons along with a fluorescent reporter of neurotransmitter release, VGLUT1-pHluorin. We find that increased expression of alpha-synuclein inhibits neurotransmitter release, and does so by reducing the size of the synaptic vesicle recycling pool. A mutation in alpha-synuclein linked to Parkinson's disease (A30P) that inhibits membrane binding abolishes this effect; however, the C-terminus is not required. Further, alpha-synuclein overexpression inhibits neurotransmitter release in hippocampal slices from transgenic mice. Importantly, we also show that increased alpha-synuclein expression inhibits neurotransmitter release in midbrain dopamine neurons. Biochemical experiments suggest that the decrease in recycling pool size may be due to a selective decrease in complexin and synapsin proteins. We also present preliminary evidence indicating a role for alpha-synuclein in the control of mitochondrial morphology. Overexpression of alpha-synuclein causes mitochondrial fragmentation, while the A30P mutant has a diminished ability to fragment mitochondria.

These experiments clarify the function of alpha-synuclein at the nerve terminal, and suggest a role for increased expression of the protein and altered synaptic activity in the initiation of Parkinson's disease pathogenesis. Further, we provide evidence for a previously unappreciated link between alpha-synuclein and mitochondria, an organelle whose dysfunction is central to the degeneration of neurons in Parkinson's disease.

Main Content
Current View